Clinical Trial Update: Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating an omega-3 fatty acid-based anti-cancer therapy in patients with metastatic triple-negative inflammatory breast cancer. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Omega-3 fatty acid-based anti-cancer therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Inflammatory Carcinoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-09-04